Newsroom | 5817 results
Sorted by: Latest
-
RestorixHealth Announces 2026 Center Recognition Awards
METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce the wound and hyperbaric center recipients of their Center Recognition Awards program for the awards period January-June 2026. These awards champion a center’s commitment to the highest quality of patient care, optimal outcomes and exceptional patient satisfaction over a six-month period. “Earning a Center Recognition award is a tremendous achievement. These outstanding team...
-
Amorepacific and Junevity Partner to Develop Next-Generation Products for Skin Rejuvenation
SAN FRANCISCO & SEOUL, South Korea--(BUSINESS WIRE)--Amorepacific and Junevity Partner to Develop Next-Generation Products for Skin Rejuvenation...
-
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to fifteen newly hired non-executive employees consisting of options to purchase an aggregate of 334,810 common shares of the Company (the "Options") with effective grant dates of September...
-
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the appointment of Sebastian Blöte as Country Manager for Germany, effective October 1, 2026.Mr. Blöte will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections w...
-
Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed its Management Information Circular (the "Circular") and related proxy materials for its annual general and special meeting of shareholders to be held on October 30, 2026 (the “Meeting”), as it prepares for a potential listing on a senior U.S. exchange. At the Meeting, shareholders will be asked to approve three special resolutions relating to: (1) a...
-
AndHealth Expands Specialty Care Access to Illinois, Partnering with the Illinois Primary Health Care Association and Christopher Rural Health Planning Corporation
CHRISTOPHER, Ill. & COLUMBUS, Ohio--(BUSINESS WIRE)--AndHealth announces first Illinois CHC partner as it enters its third state, bringing whole-person specialty care to medically underserved patients....
-
Mountainside Issues Warning on Kratom and Cychlorphine Following Ole Miss Student Deaths
NEW YORK--(BUSINESS WIRE)--Following the deaths of two University of Mississippi students, Mountainside is urging families and college communities to seek reliable information about kratom and cychlorphine, an emerging synthetic opioid. Authorities reported finding retail-packaged kratom during two separate death investigations. They have not determined that kratom or any other substance contributed to either death, established that the deaths are connected, or reported finding cychlorphine in...
-
Study Published in The Journal of Clinical Psychiatry Shows Potential Benefit of Alternative Maintenance Dosing Strategies for Paliperidone Palmitate in Treatment of Schizophrenia
PRINCETON, N.J.--(BUSINESS WIRE)--Study Published Shows Potential Benefit of Alternative Maintenance Dosing Strategies for Paliperidone Palmitate in Treatment of Schizophrenia...
-
N-Zyme Biomedical Program Receives US$2.76 Million NIH Award to Advance Fosamprenavir for PPI-Refractory GERD
WAUWATOSA, Wis. & NEWARK, Del.--(BUSINESS WIRE)--N-Zyme Biomedical Program Receives US$2.76 Million NIH Award to Advance Fosamprenavir for PPI-Refractory GERD...
-
Mediterranean Network for Haemoglobinopathies startet in Rom und bringt klinische Experten und Patientenvertreter zusammen, um eine gerechte Versorgung voranzubringen
ROM--(BUSINESS WIRE)--Das Mediterranean Network for Haemoglobinopathies (MNfH) wurde kürzlich im Palazzo Wedekind in Rom ins Leben gerufen. Es bringt führende medizinische Fachkräfte und Patientenvertreter aus Zypern, Griechenland und Italien mit der Thalassaemia International Federation (TIF) zusammen. Die unabhängige regionale Plattform wird von Avanzanite Bioscience als Gründungssponsor unterstützt. Sie soll Fachwissen über Ländergrenzen hinweg vernetzen, der Perspektive von Patienten mehr G...